Lipid and biomarker differences between Raltegravir and Atazanavir/Ritonavir at 48 Weeks in the Raltegravir Atazanavir Naïve (RAN) study
Tanvir Bell, Martine Diez, Xiaoying Yu, Chi Nguyen, Claudia Kozinetz
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Lipid and biomarker differences between Raltegravir and Atazanavir/Ritonavir at 48 Weeks in the Raltegravir Atazanavir Naïve (RAN) study'. Together they form a unique fingerprint.